Sign up to save your podcasts
Or
Share The Infamous Erlotinib Study
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Infamous Erlotinib Study
An infamous study that led to a drug approval of limited benefit, but still made its way into an episode of Better Call Saul.
Erlotinib + gemcitabine vs. gemcitabine: https://doi.org/10.1200/jco.2006.07.9525
View all episodes
By John Bossaer
4.9
179179 ratings
An infamous study that led to a drug approval of limited benefit, but still made its way into an episode of Better Call Saul.
Erlotinib + gemcitabine vs. gemcitabine: https://doi.org/10.1200/jco.2006.07.9525
More shows like OncoPharm
View all
JAMA Editors' Summary
129 Listeners
NEJM This Week
324 Listeners
JAMA Clinical Reviews
493 Listeners
The Curbsiders Internal Medicine Podcast
3,330 Listeners
Up First from NPR
56,166 Listeners
Core IM | Internal Medicine Podcast
1,090 Listeners
The ONS Podcast
192 Listeners
ASCO Guidelines
43 Listeners
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
716 Listeners
OncLive® On Air
21 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
The Curious Clinicians
366 Listeners
WolverHeme Happy Hour
29 Listeners
Two Onc Docs
169 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
39 Listeners